Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Keiko Fujimori declared winner of Peru presidential race
Ukrainian rescuers clear rubble as Kyiv mourns 30 killed in Russian attack
Monaco blast suspect is a Ukrainian woman who fled to Germany
Clinical trials begin for two potential Ebola treatments
India issues notice to Telegram, Signal on concerns over usernames, source says
Blast at Damascus cafe kills nine, wounds 20
Rebels in Indonesia's Papua kill American pilot, burn plane
Russian air strikes kill 10, injure more than 50 in Ukraine's Kyiv
